GSK Revenue 2010-2023 | GSK
GSK annual/quarterly revenue history and growth rate from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- GSK revenue for the quarter ending March 31, 2023 was $8.444B, a 35.65% decline year-over-year.
- GSK revenue for the twelve months ending March 31, 2023 was $31.592B, a 36.57% decline year-over-year.
- GSK annual revenue for 2022 was $36.271B, a 22.68% decline from 2021.
- GSK annual revenue for 2021 was $46.91B, a 7.14% increase from 2020.
- GSK annual revenue for 2020 was $43.783B, a 1.58% increase from 2019.
GSK Annual Revenue
(Millions of US $) |
| 2022 |
$36,271 |
| 2021 |
$46,910 |
| 2020 |
$43,783 |
| 2019 |
$43,100 |
| 2018 |
$41,140 |
| 2017 |
$38,904 |
| 2016 |
$37,798 |
| 2015 |
$36,578 |
| 2014 |
$37,916 |
| 2013 |
$41,475 |
| 2012 |
$41,896 |
| 2011 |
$43,940 |
| 2010 |
$43,903 |
| 2009 |
$44,421 |
GSK Quarterly Revenue
(Millions of US $) |
| 2023-03-31 |
$8,444 |
| 2022-12-31 |
$5,228 |
| 2022-09-30 |
$9,221 |
| 2022-06-30 |
$8,699 |
| 2022-03-31 |
$13,123 |
| 2021-12-31 |
$12,853 |
| 2021-09-30 |
$12,516 |
| 2021-06-30 |
$11,311 |
| 2021-03-31 |
$10,229 |
| 2020-12-31 |
$11,509 |
| 2020-09-30 |
$11,169 |
| 2020-06-30 |
$9,461 |
| 2020-03-31 |
$11,644 |
| 2019-12-31 |
$11,509 |
| 2019-09-30 |
$11,573 |
| 2019-06-30 |
$10,040 |
| 2019-03-31 |
$9,978 |
| 2018-12-31 |
$6,661 |
| 2018-09-30 |
$10,544 |
| 2018-06-30 |
$9,949 |
| 2018-03-31 |
$13,986 |
| 2017-12-31 |
$10,128 |
| 2017-09-30 |
$10,268 |
| 2017-06-30 |
$9,361 |
| 2017-03-31 |
$9,147 |
| 2016-12-31 |
$9,429 |
| 2016-09-30 |
$9,905 |
| 2016-06-30 |
$9,373 |
| 2016-03-31 |
$8,925 |
| 2015-12-31 |
$9,617 |
| 2015-09-30 |
$9,498 |
| 2015-06-30 |
$9,020 |
| 2015-03-31 |
$8,512 |
| 2014-12-31 |
$9,319 |
| 2014-09-30 |
$9,120 |
| 2014-06-30 |
$9,472 |
| 2014-03-31 |
$9,440 |
| 2013-12-31 |
$11,235 |
| 2013-09-30 |
$10,518 |
| 2013-06-30 |
$10,166 |
| 2013-03-31 |
$9,875 |
| 2012-12-31 |
$10,782 |
| 2012-09-30 |
$10,512 |
| 2012-06-30 |
$10,210 |
| 2012-03-31 |
$10,717 |
| 2011-12-31 |
$10,990 |
| 2011-09-30 |
$11,304 |
| 2011-06-30 |
$10,950 |
| 2011-03-31 |
$10,544 |
| 2010-12-31 |
$11,636 |
| 2010-09-30 |
$10,560 |
| 2010-06-30 |
$9,196 |
| 2010-03-31 |
$11,286 |
| 2009-12-31 |
$13,218 |
| 2009-09-30 |
$11,097 |
| 2009-06-30 |
$10,527 |
| 2009-03-31 |
$9,734 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$69.327B |
$36.279B |
|
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
|
